We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-0.98%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$876M
AUM Growth
-$55.2M
(-5.9%)
Cap. Flow
-$22.6M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
15.65%
Holding
1,097
New
348
Increased
154
Reduced
158
Closed
436
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$13.9M |
| 2 |
CVS Health
CVS
|
+$12.2M |
| 3 |
Meta Platforms (Facebook)
META
|
+$11.6M |
| 4 |
Skyworks Solutions
SWKS
|
+$10.5M |
| 5 |
Nike
NKE
|
+$9.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$27.9M |
| 2 |
Starbucks
SBUX
|
+$11.8M |
| 3 |
Goldman Sachs
GS
|
+$10.9M |
| 4 |
Coca-Cola
KO
|
+$8.98M |
| 5 |
T-Mobile US
TMUS
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.88% |
| 3 | Consumer Discretionary | 12.26% |
| 4 | Financials | 8.85% |
| 5 | Communication Services | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
ICL Group
ICL
$6.65B
| $71K | 0.01% |
+12,800
| New | +$77.2K |
|
627
Cognyte Software
CGNT
$642M
| $70.2K | 0.01% |
14,600
+700
| +5% | +$3.55K |
|
628
Clover Health Investments
CLOV
$2.25B
| $67.9K | 0.01% |
62,900
-9,000
| -13% | -$10.7K |
|
629
Iovance Biotherapeutics
IOVA
$2.19B
| $65.5K | 0.01% |
14,400
-69,020
| -83% | -$451K |
|
|
PDM
630
Piedmont Realty Trust
PDM
$1.22B
| $64.3K | 0.01% |
+11,434
| New | +$78.4K |
|
631
ReNew
RNW
$2.2B
| $62.2K | 0.01% |
+11,459
| New | +$67.6K |
|
|
UNIT
632
Uniti Group
UNIT
$2.62B
| $59K | 0.01% |
+12,500
| New | +$64K |
|
|
DHC
633
Diversified Healthcare Trust
DHC
$2.28B
| $58K | 0.01% |
29,900
+1,800
| +6% | +$4.56K |
|
|
INFN
634
DELISTED
Infinera Corporation Common Stock
INFN
| $57.3K | 0.01% |
+13,700
| New | +$59.2K |
|
635
Equinox Gold
EQX
$7.51B
| $55.8K | 0.01% |
+13,200
| New | +$63.7K |
|
636
Banco Santander
SAN
$200B
| $51.1K | 0.01% |
+13,600
| New | +$51.6K |
|
637
Energy Vault
NRGV
$531M
| $47.2K | 0.01% |
+18,500
| New | +$55.4K |
|
638
Rigetti Computing
RGTI
$5.2B
| $44.8K | 0.01% |
+33,700
| New | +$64.6K |
|
639
Microvision
MVIS
$88.8M
| $43.6K | 0.01% |
19,900
-23,500
| -54% | -$71.7K |
|
640
Ginkgo Bioworks
DNA
$487M
| $43.1K | ﹤0.01% |
+595
| New | +$47.6K |
|
|
JMIA
641
Jumia Technologies
JMIA
$752M
| $43K | ﹤0.01% |
+16,300
| New | +$56.4K |
|
|
NXDR
642
Nextdoor Holdings
NXDR
$870M
| $42.4K | ﹤0.01% |
+23,313
| New | +$57.7K |
|
|
TSP
643
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $39.5K | ﹤0.01% |
+25,300
| New | +$44.2K |
|
644
B2Gold
BTG
$5.16B
| $38.4K | ﹤0.01% |
13,300
-69,000
| -84% | -$225K |
|
645
SmartRent
SMRT
$186M
| $38.4K | ﹤0.01% |
14,700
+1,605
| +12% | +$5.46K |
|
|
SRTA
646
Strata Critical Medical Inc
SRTA
$445M
| $38.3K | ﹤0.01% |
+14,800
| New | +$52K |
|
647
Accuray
ARAY
$26.8M
| $38.1K | ﹤0.01% |
+14,000
| New | +$46.2K |
|
648
Humacyte
HUMA
$182M
| $37K | ﹤0.01% |
12,641
+2,100
| +20% | +$6.95K |
|
649
SelectQuote
SLQT
$128M
| $36.6K | ﹤0.01% |
31,300
-7,600
| -20% | -$11.5K |
|
|
SOL
650
DELISTED
Emeren Group
SOL
| $30.8K | ﹤0.01% |
+10,015
| New | +$34.8K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Bayesian Capital Management held 1,097 positions worth $876M, down 5.9% from $931M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bayesian Capital Management's Q3 2023 filing shows 348 new, 154 increased, 158 reduced and 436 closed positions. Its largest new stake was Walt Disney: 162,687 shares worth $13.2M. The largest sale was NVIDIA, an estimated $27.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Bayesian Capital Management's largest Q3 2023 buy was Walt Disney: 162,687 shares worth $13.2M.
- Bayesian Capital Management added most to CVS Health in Q3 2023, an estimated $12.2M increase.
- Bayesian Capital Management's biggest Q3 2023 reduction was Coca-Cola, cutting an estimated $8.98M.
- Bayesian Capital Management fully exited NVIDIA in Q3 2023, selling an estimated $27.9M.
- Bayesian Capital Management's ten largest holdings make up 16% of its $876M portfolio in Q3 2023.
- Bayesian Capital Management opened 348 new positions and closed 436 in Q3 2023.
- Bayesian Capital Management's portfolio value fell 5.9% quarter-over-quarter to $876M.
Based on Bayesian Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.